Fifth Third Bancorp Astrazeneca PLC Transaction History

Fifth Third Bancorp

  • $25.9 Billion
  • Q1 2025

A detailed history of Fifth Third Bancorp transactions in Astrazeneca PLC stock. As of the latest transaction made, Fifth Third Bancorp holds 5,269 shares of AZN stock, worth $363,297. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,269
Previous 5,538 4.86%
Holding current value
$363,297
Previous $362,000 6.91%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025
SELL
$65.37 - $77.96 $17,584 - $20,971
-269 Reduced 4.86%
5,269 $387,000
Q4 2024

Jan 21, 2025
SELL
$63.2 - $79.58 $705,564 - $888,431
-11,164 Reduced 66.84%
5,538 $362,000
Q3 2024

Oct 17, 2024
BUY
$76.67 - $87.62 $51,675 - $59,055
674 Added 4.21%
16,702 $1.3 Million
Q2 2024

Jul 22, 2024
SELL
$66.81 - $80.83 $45,898 - $55,530
-687 Reduced 4.11%
16,028 $1.25 Million
Q1 2024

Apr 23, 2024
SELL
$61.03 - $69.57 $88,188 - $100,528
-1,445 Reduced 7.96%
16,715 $1.13 Million
Q4 2023

Jan 19, 2024
BUY
$61.89 - $69.28 $172,054 - $192,598
2,780 Added 18.08%
18,160 $1.22 Million
Q3 2023

Oct 31, 2023
SELL
$64.85 - $71.7 $9,532 - $10,539
-147 Reduced 0.95%
15,380 $1.04 Million
Q2 2023

Jul 25, 2023
BUY
$69.91 - $75.81 $163,379 - $177,167
2,337 Added 17.72%
15,527 $1.11 Million
Q1 2023

Apr 24, 2023
BUY
$63.15 - $71.6 $129,331 - $146,636
2,048 Added 18.38%
13,190 $915,000
Q4 2022

Jan 25, 2023
SELL
$54.21 - $70.44 $181,549 - $235,903
-3,349 Reduced 23.11%
11,142 $0
Q3 2022

Oct 25, 2022
BUY
$53.02 - $135.75 $377,661 - $966,947
7,123 Added 96.67%
14,491 $795,000
Q2 2022

Aug 04, 2022
BUY
$59.26 - $71.14 $235,143 - $282,283
3,968 Added 116.71%
7,368 $487,000
Q1 2022

Apr 19, 2022
SELL
$55.72 - $67.12 $28,417 - $34,231
-510 Reduced 13.04%
3,400 $226,000
Q4 2021

Feb 01, 2022
SELL
$54.02 - $63.83 $64,121 - $75,766
-1,187 Reduced 23.29%
3,910 $228,000
Q3 2021

Oct 15, 2021
BUY
$55.56 - $60.79 $114,175 - $124,923
2,055 Added 67.55%
5,097 $306,000
Q2 2021

Aug 06, 2021
SELL
$48.42 - $60.18 $141,919 - $176,387
-2,931 Reduced 49.07%
3,042 $182,000
Q1 2021

May 07, 2021
BUY
$47.16 - $54.44 $53,243 - $61,462
1,129 Added 23.31%
5,973 $297,000
Q4 2020

Feb 16, 2021
BUY
$48.52 - $58.02 $2,328 - $2,784
48 Added 1.0%
4,844 $242,000
Q3 2020

Nov 09, 2020
BUY
$53.07 - $61.1 $74,510 - $85,784
1,404 Added 41.39%
4,796 $263,000
Q2 2020

Aug 05, 2020
SELL
$43.1 - $55.31 $20,817 - $26,714
-483 Reduced 12.46%
3,392 $179,000
Q1 2020

May 05, 2020
SELL
$37.79 - $51.33 $47,350 - $64,316
-1,253 Reduced 24.43%
3,875 $173,000
Q4 2019

Feb 14, 2020
BUY
$42.46 - $50.46 $11,082 - $13,170
261 Added 5.36%
5,128 $256,000
Q3 2019

Nov 14, 2019
SELL
$40.12 - $45.47 $33,580 - $38,058
-837 Reduced 14.67%
4,867 $217,000
Q2 2019

Aug 07, 2019
SELL
$37.28 - $41.68 $4,883 - $5,460
-131 Reduced 2.25%
5,704 $235,000
Q1 2019

May 14, 2019
SELL
$35.49 - $43.02 $455,407 - $552,032
-12,832 Reduced 68.74%
5,835 $236,000
Q4 2018

Feb 14, 2019
SELL
$36.86 - $41.49 $181,830 - $204,670
-4,933 Reduced 20.9%
18,667 $709,000
Q3 2018

Nov 14, 2018
SELL
$34.76 - $39.72 $320,521 - $366,258
-9,221 Reduced 28.09%
23,600 $934,000
Q2 2018

Aug 14, 2018
SELL
$34.55 - $37.05 $320,451 - $343,638
-9,275 Reduced 22.03%
32,821 $1.15 Million
Q1 2018

May 15, 2018
SELL
$32.97 - $36.63 $232,735 - $258,571
-7,059 Reduced 14.36%
42,096 $1.47 Million
Q4 2017

Feb 14, 2018
BUY
$32.09 - $34.78 $4,075 - $4,417
127 Added 0.26%
49,155 $1.71 Million
Q3 2017

Nov 14, 2017
SELL
$28.96 - $34.0 $50,969 - $59,840
-1,760 Reduced 3.47%
49,028 $1.66 Million
Q2 2017

Aug 11, 2017
BUY
N/A
50,788
50,788 $1.73 Million

Others Institutions Holding AZN

# of Institutions
1,402
Shares Held
504M
Call Options Held
6.05M
Put Options Held
4.05M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $214B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email